Grand Pharmaceutical Group Limited
Research Grand Pharmaceutical Group Limited (0512.HK) on Bullrun: market cap HKD 16.07B, P/E 14.3, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0512.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 16.07B
- P/E14.3
- Dividend yield3.7%
- Financial periodFY2025
- RevenueHKD 12.28B
- Revenue growth5.5%
- Net incomeHKD 1.24B
- Free cash flowHKD 127.42M
- Gross margin55.2%
Valuation Snapshot
latest market cap is HKD 16.07B; P/E is 14.3; dividend yield is 3.7%.
Peer valuation comparison
Latest P/E is 14.34x versus a Healthcare sector median of 21.74x (34.0% below).
Latest dividend yield is 3.68% versus a Healthcare sector median of 2.4% (53.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 12.28B | HKD 1.24B | HKD 127.42M | 55.2% | 0.35 | HKD 1.14B | HKD 4.72B | HKD 17.02B |
| FY2024 | HKD 11.64B | HKD 2.47B | HKD 1.28B | 57.9% | 0.7 | HKD 1.34B | HKD 4.44B | HKD 16.47B |
| FY2023 | HKD 10.53B | HKD 1.88B | HKD 1.93B | 62.0% | 0.54 | HKD 1.34B | HKD 3.40B | HKD 15.16B |
| FY2022 | HKD 9.56B | HKD 2.08B | HKD 757.60M | 62.2% | 0.59 | HKD 1.44B | HKD 4.48B | HKD 14.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 16.07B | 14.3 | 3.7% | 0.17 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.17 HKD, yield 3.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.26 HKD |
| FY2024 | 0.26 HKD |
| FY2023 | 0.14 HKD |
| FY2022 | 0.11 HKD |
| FY2021 | 0.11 HKD |
About Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Grand Pharmaceutical Group Limited's market cap?
Grand Pharmaceutical Group Limited's market capitalization is HKD 16.07B.
What is Grand Pharmaceutical Group Limited's P/E ratio?
Grand Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 14.3.
Does Grand Pharmaceutical Group Limited pay a dividend?
Grand Pharmaceutical Group Limited has a dividend yield of 3.7%.
What does Grand Pharmaceutical Group Limited do?
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products.